CoChat

Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy

Saoudi, Amel, Mitsogiannis, Manuela D., Zarrouki, Faouzi, Fergus, Claire, Stojek, Erwina, Talavera, Silvia, Moore-Frederick, Dervla, Kelly, Vincent P., Goyenvalle, Aurélie, Montanaro, Federica, Muntoni, Francesco, Prenderville, Jack A., Sokolowska, Ewa, Vaillend, Cyrille · 2024 · Disease Models & Mechanisms
Cited by 14

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The severity of brain comorbidities in Duchenne muscular dystrophy (DMD) depends on the mutation position within the DMD gene and differential loss of distinct brain dystrophin isoforms (i.e. Dp427, Dp140, Dp71). Comparative studies of DMD mouse models with different mutation profiles may help to understand this genotype−phenotype relationship. The aim of this study was (1) to compare the phenotypes due to Dp427 loss in mdx5cv mice to those of mdx52 mice, which concomitantly lack Dp427 and Dp140; and (2) to evaluate replicability of phenotypes in separate laboratories. We show that mdx5cv mice displayed impaired fear conditioning and robust anxiety-related responses, the severity of which was higher in mdx52 mice. Depression-related phenotypes presented variably in these models and were difficult to replicate between laboratories. Recognition memory was unaltered or minimally affected in mdx5cv and mdx52 mice, at variance with the cognitive deficits described in the original Dp427-deficient mdx mouse, suggesting a difference related to its distinct genetic background. Our results confirm that Dp140 loss may increase the severity of emotional disturbances, and provide insights on the limits of the reproducibility of behavioral studies in DMD mouse models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dmm.050707

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 55

  1. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem. Biophys. Res. Commun., 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  2. Aupy, 2020, Long-term efficacy of AAV9-U7snRNA-mediated Exon 51 skipping in mdx52 mice, Mol. Ther. Methods Clin. Dev., 17, 1037, 10.1016/j.omtm.2020.04.025 · DOI · Paper page
  3. Barboni, 2023, Retinal dystrophins and the retinopathy of Duchenne muscular dystrophy, Prog. Retin. Eye Res., 95, 101137, 10.1016/j.preteyeres.2022.101137 · DOI
  4. Beastrom, 2011, mdx(5cv) mice manifest more severe muscle dysfunction and diaphragm force deficits than do mdx Mice, Am. J. Pathol., 179, 2464, 10.1016/j.ajpath.2011.07.009 · DOI · Paper page
  5. Billard, 1992, Cognitive functions in Duchenne muscular dystrophy: a reappraisal and comparison with spinal muscular atrophy, Neuromuscul. Disord., 2, 371, 10.1016/s0960-8966(06)80008-8 · DOI · Paper page
  6. Brownstein, 2021, RCL1 copy number variants are associated with a range of neuropsychiatric phenotypes, Mol. Psychiatry, 26, 1706, 10.1038/s41380-021-01035-y · DOI
  7. Brownstein, 2022, Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder, Am. J. Psychiatry, 179, 853, 10.1176/appi.ajp.21111175 · DOI
  8. Byers, 1993, An alternative dystrophin transcript specific to peripheral nerve, Nat. Genet., 4, 77, 10.1038/ng0593-77 · DOI · Paper page
  9. Béroud, 2007, Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy, Hum. Mutat., 28, 196, 10.1002/humu.20428 · DOI · Paper page
  10. Chapman, 1989, Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice, Proc. Natl. Acad. Sci. USA, 86, 1292, 10.1073/pnas.86.4.1292 · DOI · Paper page
  11. Chaussenot, 2015, Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: a reappraisal from sensory to executive processes, Neurobiol. Learn. Mem., 124, 111, 10.1016/j.nlm.2015.07.006 · DOI · Paper page
  12. Chelly, 1990, Dystrophin gene transcribed from different promoters in neuronal and glial cells, Nature, 344, 64, 10.1038/344064a0 · DOI · Paper page
  13. Chesshyre, 2022, Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy, J. Cachexia. Sarcopenia. Muscle, 13, 1360, 10.1002/jcsm.12914 · DOI · Paper page
  14. Colombo, 2017, Assessing mental health in boys with Duchenne muscular dystrophy: emotional, behavioural and neurodevelopmental profile in an Italian clinical sample, Eur. J. Paediatr. Neurol., 21, 639, 10.1016/j.ejpn.2017.02.007 · DOI · Paper page
  15. Cotton, 2001, Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients, Dev. Med. Child Neurol., 43, 497, 10.1017/s0012162201000913 · DOI · Paper page
  16. Cox, 1993, New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin, Nat. Genet., 4, 87, 10.1038/ng0593-87 · DOI · Paper page
  17. Deacon, 2007, A comparison of the behavior of C57BL/6 and C57BL/10 mice, Behav. Brain Res., 179, 239, 10.1016/j.bbr.2007.02.009 · DOI
  18. Desguerre, 2009, Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up, PLoS One, 4, e4347, 10.1371/journal.pone.0004347 · DOI · Paper page
  19. Engelbeen, 2021, Assessment of behavioral characteristics with procedures of minimal human interference in the mdx mouse model for Duchenne muscular dystrophy, Front. Behav. Neurosci., 14, 629043, 10.3389/fnbeh.2020.629043 · DOI · Paper page
  20. Flynn, 2021, Copy number evolution in simple and complex tandem repeats across the C57BL/6 and C57BL/10 inbred mouse lines, G3, 11, jkab184, 10.1093/g3journal/jkab184 · DOI · Paper page
  21. Goyenvalle, 2015, Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers, Nat. Med., 21, 270, 10.1038/nm.3765 · DOI · Paper page
  22. Górecki, 1992, Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters, Hum. Mol. Genet., 1, 505, 10.1093/hmg/1.7.505 · DOI · Paper page
  23. Hayward, 2022, Characterization of Alzheimer's disease-like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model, FEBS Open Biol., 12, 154, 10.1002/2211-5463.13317 · DOI
  24. Hinton, 2001, Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of Duchenne muscular dystrophy, J. Int. Neuropsychol. Soc., 7, 45, 10.1017/S1355617701711058 · DOI · Paper page
  25. Hinton, 2004, Investigation of poor academic achievement in children with duchenne muscular dystrophy, Learn Disabil. Res. Pract., 19, 146, 10.1111/j.1540-5826.2004.00098.x · DOI
  26. Hoffman, 1987, Subcellular fractionation of dystrophin to the triads of skeletal muscle, Nature, 330, 754, 10.1038/330754a0 · doi:10.1038/330754a0
  27. Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum. Mol. Genet., 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
  28. Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur. J. Neurosci., 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
  29. Lidov, 1995, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Hum. Mol. Genet., 4, 329, 10.1093/hmg/4.3.329 · DOI · Paper page
  30. Logge, 2014, Do individually ventilated cage systems generate a problem for genetic mouse model research?, Genes Brain Behav., 13, 713, 10.1111/gbb.12149 · DOI
  31. Mah, 2014, A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy, Neuromuscul. Disord., 24, 482, 10.1016/j.nmd.2014.03.008 · DOI · Paper page
  32. Maresh, 2023, Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency, Brain, 146, 252, 10.1093/brain/awac048 · DOI
  33. McLin, 2006, Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains, Eur. J. Neurosci., 24, 2191, 10.1111/j.1460-9568.2006.05111.x · DOI · Paper page
  34. Mercuri, 2019, Muscular dystrophies, Lancet, 394, 2025, 10.1016/S0140-6736(19)32910-1 · DOI · Paper page
  35. Merikangas, 2009, Copy-number variants in neurodevelopmental disorders: promises and challenges, Trends Genet., 25, 536, 10.1016/j.tig.2009.10.006 · DOI
  36. Morrow, 2010, Genomic copy number variation in disorders of cognitive development, J. Am. Acad. Child Adolesc. Psychiatry, 49, 1091, 10.1016/j.jaac.2010.08.009 · DOI · Paper page
  37. Mortazavi, 2021, Polymorphic SNPs, short tandem repeats and structural variants are responsible for differential gene expression across C57BL/6 and C57BL/10 substrains, bioRxiv 2020.03.16.993683, 10.1101/2020.03.16.993683 · doi:10.1101/2020.03.16.993683
  38. Mortazavi, 2022, SNPs, short tandem repeats, and structural variants are responsible for differential gene expression across C57BL/6 and C57BL/10 substrains, Cell Genom, 2, 100102, 10.1016/j.xgen.2022.100102 · DOI · Paper page
  39. Pasquarelli, 2017, Effect of a change in housing conditions on body weight, behavior and brain neurotransmitters in male C57BL/6J mice, Behav. Brain Res., 333, 35, 10.1016/j.bbr.2017.06.018 · DOI
  40. Pastoret, 1995, mdx mice show progressive weakness and muscle deterioration with age, J. Neurol. Sci., 129, 97, 10.1016/0022-510x(94)00276-t · DOI · Paper page
  41. Perronnet, 2010, Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies, J. Biomed. Biotechnol., 2010, 849426, 10.1155/2010/849426 · DOI
  42. Polissidis, 2017, Assessing the exploratory and anxiety-related behaviors of mice. Do different caging systems affect the outcome of behavioral tests?, Physiol. Behav., 177, 68, 10.1016/j.physbeh.2017.04.009 · DOI
  43. Rees, 2021, Copy number variation and neuropsychiatric illness, Curr. Opin. Genet. Dev., 68, 57, 10.1016/j.gde.2021.02.014 · DOI
  44. Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev. Med. Child Neurol., 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
  45. Saoudi, 2021, Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy, Dis. Model. Mech., 14, dmm049028, 10.1242/dmm.049028 · DOI · Paper page
  46. Saoudi, 2023, Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mdx52 mice, Mol. Ther. Nucleic Acids, 32, 173, 10.1016/j.omtn.2023.03.009 · DOI
  47. Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
  48. Sinadinos, 2015, P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy, PLoS Med., 12, e1001888, 10.1371/journal.pmed.1001888 · DOI · Paper page
  49. Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS One, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
  50. Vaillend, 2017, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum. Mol. Genet., 26, 1041, 10.1093/hmg/ddx013 · DOI · Paper page
  51. Vaillend, 1999, Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins, Neuromuscul. Disord., 9, 296, 10.1016/s0960-8966(99)00029-2 · DOI · Paper page
  52. Vaillend, 1998, Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products, Neuroscience, 86, 53, 10.1016/s0306-4522(98)00023-2 · DOI · Paper page
  53. Wersinger, 2011, Reevaluation of dystrophin localization in the mouse retina, Invest. Ophthalmol. Vis. Sci., 52, 7901, 10.1167/iovs.11-7519 · doi:10.1167/iovs.11-7519
  54. Yamamoto, 2010, Reduction of abnormal behavioral response to brief restraint by information from other mice in dystrophin-deficient mdx mice, Neuromuscul. Disord., 20, 505, 10.1016/j.nmd.2010.05.006 · DOI · Paper page
  55. Zarrouki, 2022, Partial restoration of brain dystrophin and behavioral deficits by exon skipping in the muscular dystrophy X-linked (mdx) mouse, Ann. Neurol., 92, 213, 10.1002/ana.26409 · DOI

Cited by

Metadata

Authors
Saoudi, A., Mitsogiannis, M. D., Zarrouki, F., Fergus, C., Stojek, E., Talavera, S., Moore-Frederick, D., Kelly, V. P., Goyenvalle, A., Montanaro, F., Muntoni, F., Prenderville, J. A., Sokolowska, E., & Vaillend, C.
Affiliations
  • CNRS, Institut des Neurosciences Paris-Saclay, Université Paris-Saclay 1 , 91400 Saclay ,
  • Transpharmation Ireland Ltd, Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin 2 3 , Dublin ,
  • School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 4 , Dublin ,
  • UVSQ, Inserm, END-ICAP, Université Paris-Saclay 2 , Versailles ,
  • Great Ormond Street Institute of Child Health, Dubowitz Neuromuscular Centre, University College London 5 , London ,
Venue
Disease Models & Mechanisms
Published
2024-12-01
Volume
17
Issue
12
ISSN
  • 1754-8403
  • 1754-8411
Cited by
14
References
6
Language
en
Funders
  • Horizon 2020 Framework Programme (847826)
  • Centre National de la Recherche Scientifique
  • Université Paris-Saclay
  • Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
  • Transpharmation Poland Ltd

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.